AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02421523 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Aim 1 Exercise Dosing
Description: The maximal voluntary contraction (MVC) will be determined for each subject. The first four subjects will exercise at an intensity of \~30% of the subject's MVC. Subjects will be asked to perform \~4 sets of 6 reps of knee extension and knee flexion contractions. 48hs after the exercise is completed a safety assessment will be performed for muscle damage. If none has occurred, four additional subjects will perform the exercise at the next level of intensity (\~50% MVC). Similarly, if no damage has occurred at \~50% MVC, four more subjects exercise at \~70% MVC. All safety measures will be performed 48hrs after the exercise has been completed at each of the levels. These safety assessments include T2 MRI, Spectroscopic relaxometry, pain rating scale, and CK levels.
Study NCT02421523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Aim 2 Control group
Description: This group will receive safety assessments at baseline, 1 week, 6 weeks, and 12 weeks including T2 MRI, Spectroscopic relaxometry, pain rating scale, and CK levels. They will also receive safety assessments at 3 weeks and 9 weeks that will include the pain rating scale and CK levels. Participants in this group may also be tested for strength assessments (of the knee flexors and extensors) and time to climb 4 stairs.
Study NCT01658670 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care Group
Description: The EUC group is provided access to the exercise facility and regular facility staff for the 18 month study period.
Study NCT01658670 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HEART Camp (HC) Intervention Group
Description: The HC intervention group will be provided access to the exercise facility for the 18 month study period and will also receive the cognitive-behavioral intervention (knowledge, attitudes, self-efficacy, behavioral self-management skills and social support) delivered using both group-based and individual-based strategies.
Study NCT00600483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gentamicin-collagen sponge dipped in saline
Description: 100-cm2 sponge
Study NCT03060915 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Actigraphy
Description: Patient's wear an actigraphy while doing the polysomnography
Study NCT01645774 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 10s injections duration
Description: 10s injections duration
Study NCT01645774 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 10s injection duration and waiting 10s before withdrawing the needle
Description: 10s injection duration and waiting 10s before withdrawing the needle
Study NCT01645774 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15s injection duration and waiting 5s before withdrawing the needle
Description: 15s injection duration and waiting 5s before withdrawing the needle
Study NCT01645774 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 5s injection duration and waiting 15s before withdrawing the needle
Description: 5s injection duration and waiting 15s before withdrawing the needle
Study NCT02304172 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thunderbeat (Group A)
Description: hemostatic device utilized intraoperatively
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Hand-Grip Strength Measurement
Description: Handgrip strength will be assessed with LaFayette Professional Hand Dynamometer, Model 5030L1, LaFayette Instruments, NY, USA). The standard position which can be achieved by 90-degree elbow flexion, shoulder abducted, and hand mid-prone positioned; 90-degree shoulder abduction and 90-degree shoulder abduction positions will be used to assess hang-grip strength. Three measurements will be requested and the maximum value of them will be recorded. 1 minute resting period will be provided between the positions at which handgrip is assessed.
Study NCT02304172 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Harmonic (Group B)
Description: hemostatic device utilized intraoperatively
Study NCT03242057 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NAVA
Description: Infant will be extubated to NAVA, settings based per protocol
Study NCT03242057 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NIPPV
Description: Infant will be extubated to NIPPV, settings detailed in protocol
Study NCT01234298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPD489 Low-Dose
Description: SPD489 20, 30, or 40 mg capsules taken once-daily for up to 26 weeks
Study NCT01234298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPD489 High-Dose
Description: SPD489 50, 60, or 70 mg capsules taken once-daily for up to 26 weeks
Study NCT01234298 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule taken once-daily for up to 26 weeks
Study NCT00576927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ramelteon
Description: Subjects demonstrating low sleep efficiencies and prolonged sleep latencies, will be randomly assigned to continue to receive SHI accompanied by either placebo or Ramelteon (8 mg). Matching placebo will be obtained and the medication pre-packaged and ordered based on the randomization results.
Study NCT03773237 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: SMOFLipid
Description: SMOFLipid will be given to HPN patients to assess the benefits or adverse effects compared to Intralipid.
Study NCT03773237 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Intralipid
Description: Intralipid will be given to HPN patients to assess the benefits or adverse effects compared to SMOFlipid
Study NCT02298868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baclofen
Study NCT00576927 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05085652 — intervention group
Intervention type: PROCEDURE
Intervention: spinal anesthesia induced hypotension in SARS-CoV-2 patients.
Description: SARS-CoV-2 infection prognosis remains unclear during pregnancy. according to ESA, ASRA and WHO regional anesthesia was recommended to use for caesarian section procedures. But at the beginning of the pandemic Chen et al shared their retrospective analyses about regional anesthesia for caesarian section and they showed high spinal anesthesia induced hypotension in 14 patients of the 17 and also again Chen and Zahng et al made another study and this time they found 57,4% hypotension incidence. In our study we aimed to find if the spinal anesthesia safe procedure in the 249 patients and one center hospital.
Study NCT01831193 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Curcumin
Study NCT01684007 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0]
Description: Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient
Study NCT01684007 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0]
Description: Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient
Study NCT01684007 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL Model SN6AD1
Description: Multifocal IOL implanted for long-term use over the lifetime of the cataract patient
Study NCT02793934 — intervention group
Intervention type: OTHER
Intervention: Scales
Description: For stroke patients there are used scales:~Modified Rankin Scale, NIH Stroke Scale , Glasgow Coma Scale, Dysphagia Severity, Rating Scale Speech or Language Impairment Severity Rating Scale, Modified Rivermead Mobility Index, Berg Balance Scale, Modified Ashworth Scale, Medical Research Council Scale, Frenchay Arm Test, Montreal Cognitive Assessment Scale, Spielberger Scale, Beck's Depression Inventory, Visual Analogue Scale, Functional Independence Measure For patients after AMI: Rankin scale, GRACE scale, MoCA, VAS, Hospital scale of anxiety and depression, Canadian classification if stenocardia~For patients after THR:~The pain of the operated joint on VAS scores The Harris scale (the total amount), Scale Lequesne (total), Hospital scale of anxiety
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Pain Threshold Measurement
Description: The sensitive pain threshold and normal pain threshold will be evaluated by a digital algometer (Wagner FDIX, Greenwich, USA) on reference points as follows: C5-C6 zygapophyseal joints' lateral points, upper trapezius (proximal, middle and distal lateral points, length measured by a tape from C7 Processus spinosus to acromion and this length will be divided equally into three parts for proximal, middle and distal lateral point), deltoid muscle (crista deltoidea), dorsum of the webspace.
Study NCT02793934 — intervention group
Intervention type: OTHER
Intervention: New model of rehabilitation
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Description: This scale was intended to be filled to assess participants' physical activity levels within the last seven days. Then, MET calculations will be done via a basic Excel Spreadsheet which is pre-defined MET values formulated inside. Scale data then obtained according to the participants' answers and recorded.
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Fatigue Impact Scale
Description: This scale has 9 items that can be answered as Strongly Disagree through Strongly Agree by numbered as 1 and 7, respectively. Then total points will be calculated and divided into 9 to achieve the Fatigue Impact Scale score. The higher points will be indicated more perceived fatigue, while lower points indicate less.
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Disabilities of Arm, Shoulder and Hand Scale (DASH)
Description: DASH has 30 items related to upper extremity function. Participants will be requested to grade some expressions related to the function within a 5-point Likert scale as follows: No difficulty: 1, Mild Difficulty:2, Moderate Difficulty: 3, Severe Difficulty: 4 and Unable to perform: 5). The symptom score of the DASH will be calculated as dividing filled items total score to filled items' number and minus one from this data then multiplying with 25. The higher points indicate a deteriorated shoulder and hand function while lower points indicate a better upper extremity function.
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Exercise Benefits/ Barriers Scale
Description: Exercise Benefits/Barriers Scale has 43 items each can be graded within a four-point Likert type scale. Barrier items are reverse coded. 43 items are all related to exercise and exercise beliefs in both in the aspect of health and general. Strongly disagree, disagree, agree, strongly agree will be scored as 1,2,3,4 or vice versa whether the item should de reversely coded, respectively. Total scores ranged between 29 and 172. The barrier scale score is ranged between 14 and 56. The benefits scale is also ranged between 29 and 116. The higher the score of Barriers scale, the greater the perception of barriers to exercise.
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Beck Depression Scale
Description: Beck Depression Scale has 21 items each can be scored within 0 to 3. All items are related to the depressive mood of a participant. The higher the score of the Beck Depression Scale, the higher the depression level.
Study NCT03190681 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ritalin 10Mg Tablet
Description: ingestion of an oral single-dose
Study NCT03190681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritalin 10Mg Tablet
Description: ingestion of an oral single-dose
Study NCT00878813 — intervention group
Intervention type: PROCEDURE
Intervention: Sampling of 15ml blood
Description: On admission, 2 x 7.5ml blood tubes will be drawn during the first routine blood sampling
Study NCT03657693 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: NICU MRI
Description: MRI device that is not FDA approved.
Study NCT03657693 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Polysomnography
Description: Polysomnography to better determine obstruction index in the airway.
Study NCT02990481 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TRK-950
Description: Intravenously over 60 minutes, on day 1, 8 and 15 of each cycle
Study NCT02990481 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TRK-950
Description: Low dose: intravenously over 60 minutes, on day 1, 8, 15 and 22 of each cycle~High dose: intravenously over 60 minutes, on day 1 and 15 of each cycle
Study NCT02990481 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TRK-950
Description: Low dose: Intravenously over 60 minutes, on day 1, 8, 15 and 22 of each cycle
Study NCT00878813 — intervention group
Intervention type: PROCEDURE
Intervention: Blood-Sampling
Description: On day 1 after intra-arterial thrombolysis, 2 x 7.5ml blood tubes on the following routine blood-sampling will be drawn.
Study NCT04461613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Original IPAQ followed by a revised one.
Description: Comparing two questionnaires (a revised version and an original International Physical Activity Questionnaire short form) with an activity diary.
Study NCT03969290 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Verofilcon A contact lenses
Description: Daily disposable silicone hydrogel contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)
Study NCT03969290 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Verofilcon A contact lenses
Description: Daily disposable silicone hydrogel contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)
Study NCT03969290 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Etafilcon A contact lenses
Description: Daily disposable contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)
Study NCT03969290 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Etafilcon A contact lenses
Description: Daily disposable contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)
Study NCT01346943 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Altura Medical Abdominal Aortic Aneurysm Stent-Graft
Description: Altura Medical AAA Stent Graft System
Study NCT01703052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF 6001 SD or placebo
Description: Dry Powder Inhaler
Study NCT01703052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF 6001 MD or placebo
Description: Dry Powder Inhaler
Study NCT02793934 — intervention group
Intervention type: OTHER
Intervention: Old model of rehabilitation
Study NCT02793934 — intervention group
Intervention type: OTHER
Intervention: ICF reader
Study NCT03975335 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health education
Description: In this health education intervention, emphasis is given on evoking adolescents' internal desire to change, supporting self-efficacy to be changed, guiding self-regulatory ways along with facilitating desired changing process by empowering them with choices and skills.
Study NCT05251844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: receiving an email
Description: The email informed that the employee has had been identified as having accessed a patient's electronic medical record without a known work-related purpose and that unauthorized access is a privacy violation.
Study NCT04340479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound lung imaging as part of FAST+ evaluation
Description: FAST+ evaluations will expand on the traditional FAST exam to systematically survey bilateral lung fields. Traditional FAST evaluation will survey the perihepatic, perisplenic, pelvic, and pericardial areas. Representative images will be saved by the performing provider for further evaluation. Up to sixteen areas in total will be included in FAST+ evaluation:~1. Anterior midclavicular right and left (apical, medial, basal)~2. Posterior paraspinal right and left\* (apical, medial, basal)~   \*Posterior lung evaluation will be omitted if patients are at risk for further traumatic injury from repeated side rolling.~3. Lateral axillary medial right and left (apical and basal)~Specifically, we will document the presence or absence of bilateral, diffuse pleural line abnormalities, subpleural consolidations, white lung areas and thick, irregular vertical artifacts in these lung fields by ultrasound and will record these findings.
Study NCT01837394 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Block of the SN and ONP
Description: 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site
Study NCT03975335 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Carrier Guidance
Description: Carrier opportunities and counselling
Study NCT04359862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: 25 patients sedated with Sevoflurane via inhalation, starting with 6 ml/h and changing every 15 minutes until an adequate level of sedation is achieved ( BIS 40-50)
Study NCT04359862 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: 25 patients standard sedation with intravenous propofol, starting with 2 mg/kg/h and changing every 15 minutes until an adequate level of sedation is achieved ( BIS 40-50)
Study NCT04461613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Revised IPAQ followed by an original one.
Description: Comparing two questionnaires (a revised version and an original International Physical Activity Questionnaire short form) with an activity diary.
Study NCT03704844 — intervention group
Intervention type: OTHER
Intervention: non applicable
Description: non applicable
Study NCT04280133 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Video Tool
Description: The video educational tool was written by the investigators in collaboration with a panel of experts on CAR T-cell therapy, medical ethicists, palliative care clinicians, and oncologists.
Study NCT04239144 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral sympathectomy
Description: Bilateral sympathectomy will be performed using video assisted thoracoscopy using the Ethicon Ultracision device. The denervation consisted of left lower 1/3 stellate ganglion and T3- T4 thoracic interspinal space videothoracoscopic cutting, isolating the whole sympathetic chain between these two points using ultracision device on the nerve branches. The cephalic portion of the stellate ganglion was preserved to avoid Horner's syndrome and the electrocautery use was also avoided due to the same reason. The nerve was blocked using Ultracision device to avoid thermic lesion of the stellate ganglion. Hemodynamic and echocardiographic behaviors were continuously monitored during these surgical maneuvers.
Study NCT04239144 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter ablation
Description: Catheter ablation - patients allocated to this group will undergone epicardial and endocardial catheter ablation with the use of irrigated contact sensor tip catheter. Voltage electroanatomical mapping using Carto System will be performed in all cases and if hemodynamically stable VT is induced activation mapping will also be performed. The aim of the ablation is to eliminate the clinical VT additionally to substrate modification. The result of ablation will be defined as (1) complete success; (2) partial success and (3) failure.
Study NCT00957190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dorzolamide 20 mg and Timolol 5 mg
Description: Twice daily in the affected eye(s)
Study NCT02220530 — intervention group
Intervention type: DRUG
Intervention: Conscious sedation with iv midazolam and fentanyl.
Description: Sedation group: Conscious sedation with iv midazolam and fentanyl dosed according to age, weight and baseline conditions of the patients.
Study NCT01983046 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Three different mixture of acetate, butyrate and propionate and palcebo
Study NCT01983046 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Three different mixture of acetate, butyrate and propionate and palcebo
Study NCT02002624 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PSI
Study NCT01837394 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo block
Description: 7.5 ml of isotonic saline solution 154 mmol/l injected at each site
Study NCT02002624 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional instrumentation
Study NCT01837394 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Study NCT01837394 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paracetamol
Study NCT01837394 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: 5 mg as needed
Study NCT01837394 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Morphine
Description: 5 mg as needed
Study NCT01186315 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prolonged Exposure Therapy
Description: These treatments include repeated exposure to intrusive trauma-related memories in a safe and structured manner designed to reduce emotional arousal and facilitate processing of trauma-related memories.
Study NCT01837394 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron
Description: 4 mg i.v. as needed in the PACU
Study NCT01837394 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ondansetron
Description: 4 mg i.v. as needed in the PACU